Neoclease

Curated by Signal

Provider of precision gene editing solutions throug synthetic biology and AI algorithms for advancing genomic medicine

Overview

Provider of precision gene editing solutions throug synthetic biology and AI algorithms for advancing genomic medicine. It develop custom nucleases, gene-editing enzymes designed to target specific genes or diseases.

Key facts

Founded: 2023
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Gusto Global
Developer of microbiome technology to detect infectious diseases
Life Sciences TechnologyMorrisville, United States
Opticyte
Developing an oximeter for real-time monitoring of cellular oxygenation and perfusion
Life Sciences TechnologySeattle, United States
Mesuron
Developer of heart screening devices for providers
Life Sciences TechnologyLatham, United States

About Neoclease

What does Neoclease do?

Provider of precision gene editing solutions throug synthetic biology and AI algorithms for advancing genomic medicine.

Where is Neoclease headquartered?

Neoclease is headquartered in Boston, United States.

When was Neoclease founded?

Neoclease was founded in 2023.

Which sector is Neoclease in?

Neoclease operates in Life Sciences Technology.

Who are Neoclease's competitors?

Companies similar to Neoclease include Gusto Global, Opticyte, and Mesuron.